pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-196a-1 |
Genomic Coordinates | chr17: 48632490 - 48632559 |
Synonyms | MIRN196-1, MIRN196A1, MIR196A1 |
Description | Homo sapiens miR-196a-1 stem-loop |
Comment | Lagos-Quintana et al. . |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-196a-2 |
Genomic Coordinates | chr12: 53991738 - 53991847 |
Synonyms | MIRN196-2, MIRN196A2, MIR196A2 |
Description | Homo sapiens miR-196a-2 stem-loop |
Comment | This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-196a-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 25| UAGGUAGUUUCAUGUUGUUGGG |46 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | HOXB8 | ||||||||||||||||||||
Synonyms | HOX2, HOX2D, Hox-2.4 | ||||||||||||||||||||
Description | homeobox B8 | ||||||||||||||||||||
Transcript | NM_024016 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on HOXB8 | |||||||||||||||||||||
3'UTR of HOXB8 (miRNA target sites are highlighted) |
>HOXB8|NM_024016|3'UTR
1 GCTTCAGCTGGGACTGCCAGGGCCGCGGCCGCCCGCACGTCCGCGGGTCCCGGCCGCGCCGCCGCCGCGCGCCCCTGCCC
81 GAGAGAGCTCTGGCCCCGCTAGCGGGGCCAGGAGCCGGGCCTCCCACCGCAGCGTCCCCCGCCGCGCCAGTCCCCGCTAG
161 TGGTAGTATCTCGTAATAGCTTCTGTGTGTGAGCTACCGTGGATCTCCTTCCCTTCTCTTGGGGGCCGGGGGGAAAGAAA
241 AGGATTTAAGCAAAGGCTCCCTCGCCCTGTGAGGGCGAGCGGCAAAGGCCCGGCTGAGCCCCCCATGCCCCTCCCCTCCC
321 CGTGTAAAAAGCCTCCTTGTGCAATTGTCTTTTTTTTCCTTTGAACGTGCTTCTTTGTAATGACCAAGGTACCGATTTCT
401 GCTAAGTTCTCCCAACAACATGAAACTGCCTATTCACGCCGTAATTCTTTCTGTCTCCCTTCTCTCTCTCTCTCTCGCTC
481 GCTCGCTCTCGCTCTCGCTCTCTCTCGCTGCGTCCTCATTTCCCCTCCCAATCCTCTCTCCCCTCTGCAACCCCCCAGCT
561 CGCTGGCTTTCTCTCTGGCTTCTCTCTTTTCCTCCTCCACCCACCCCCTTTGGTTTGACAATTTTGTCTTAAGTGTTTCT
641 CAAAAGAGGTTACTTTAGTTAGCATGCGCGCTGTGGGCAATTGTTACAAGTGTTCTTAGGTTTACTGTGAAGAGAATGTA
721 TTCTGTATCCGTGAATTGCTTTATGGGGGGGAGGGAGGGCTAATTATATATTTTGTTGTTCCTCTATACTTTGTTCTGTT
801 GTCTGCGCCTGAAAAGGGCGGAAGAGTTACAATAAAGTTTACAAGCGAGAACCCGAAAAAAAAAAAA
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HeLa |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
MiR-196-directed cleavage of HOXB8 mRNA.//miR-196a inhibited luciferase expression from the construct with the complementary site from HOXB8 mRNA.
... - Yekta S; Shih IH; Bartel DP, 2004, Science (New York, N.Y.). |
Article |
- Yekta S; Shih IH; Bartel DP - Science (New York, N.Y.), 2004
MicroRNAs (miRNAs) are endogenous approximately 22-nucleotide RNAs, some of which are known to play important regulatory roles in animals by targeting the messages of protein-coding genes for translational repression. We find that miR-196, a miRNA encoded at three paralogous locations in the A, B, and C mammalian HOX clusters, has extensive, evolutionarily conserved complementarity to messages of HOXB8, HOXC8, and HOXD8. RNA fragments diagnostic of miR-196-directed cleavage of HOXB8 were detected in mouse embryos. Cell culture experiments demonstrated down-regulation of HOXB8, HOXC8, HOXD8, and HOXA7 and supported the cleavage mechanism for miR-196-directed repression of HOXB8. These results point to a miRNA-mediated mechanism for the posttranscriptional restriction of HOX gene expression during vertebrate development and demonstrate that metazoan miRNAs can repress expression of their natural targets through mRNA cleavage in addition to inhibiting productive translation.
LinkOut: [PMID: 15105502]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HL60 |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
Exogenous expressed miR-196 repressed expression of HOXB8 via cleaving miRNAs.
... - Kawasaki H; Taira K, 2004, Nucleic acids symposium series (2004). |
Article |
- Kawasaki H; Taira K - Nucleic acids symposium series (2004), 2004
MicroRNAs (miRNAs) are endogenous small RNAs (approximately 21-25 nts) that can regulate gene expression at a post-transcriptional level. Recently a large number of miRNAs have been identified from plants and animals. In addition, it has been reported that these small RNAs can participate in cell differentiation of developmental timing. In this study, we show that microRNA-196 (miR-196) inhibits HOXB8 expression in myeloid differentiation of HL 60 cells. MiR-196 has perfect complementarity with target sequence of 3'-UTR in HOXB8 mRNA. Exogenous expressed miR-196 repressed expression of HOXB8 via cleaving mRNAs. Moreover miR-196 enhanced myeloid differentiation of HL60 cells. These results suggest that miR-196 participates in myeloid differentiation of HL60 cells via regulation of HOXB8 expression.
LinkOut: [PMID: 17150553]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HeLa |
Disease | MIMAT0000226 |
Location of target site | 3'UTR |
Tools used in this research | Literature survey |
Original Description (Extracted from the article) |
...
"The results (Figure 5B) indicate that miR-196a induced potent inhibition of the expression of the target reporter gene
... - Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; et al., 2008, PloS one. |
Article |
- Ohnishi Y; Tamura Y; Yoshida M; Tokunaga K; et al. - PloS one, 2008
Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically inhibiting the expression of disease-associated alleles without suppressing the expression of corresponding wild-type alleles. To realize such allele-specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital; however, it is also difficult. In a previous study, we developed an assay system to assess ASP-RNAi with mutant and wild-type reporter alleles encoding the Photinus and Renilla luciferase genes. In line with experiments using the system, we realized that it is necessary and important to enhance allele discrimination between mutant and corresponding wild-type alleles. Here, we describe the improvement of ASP-RNAi against mutant alleles carrying single nucleotide variations by introducing base substitutions into siRNA sequences, where original variations are present in the central position. Artificially mismatched siRNAs or short-hairpin RNAs (shRNAs) against mutant alleles of the human Prion Protein (PRNP) gene, which appear to be associated with susceptibility to prion diseases, were examined using this assessment system. The data indicates that introduction of a one-base mismatch into the siRNAs and shRNAs was able to enhance discrimination between the mutant and wild-type alleles. Interestingly, the introduced mismatches that conferred marked improvement in ASP-RNAi, appeared to be largely present in the guide siRNA elements, corresponding to the 'seed region' of microRNAs. Due to the essential role of the 'seed region' of microRNAs in their association with target RNAs, it is conceivable that disruption of the base-pairing interactions in the corresponding seed region, as well as the central position (involved in cleavage of target RNAs), of guide siRNA elements could influence allele discrimination. In addition, we also suggest that nucleotide mismatches at the 3'-ends of sense-strand siRNA elements, which possibly increase the assembly of antisense-strand (guide) siRNAs into RNA-induced silencing complexes (RISCs), may enhance ASP-RNAi in the case of inert siRNA duplexes. Therefore, the data presented here suggest that structural modification of functional portions of an siRNA duplex by base substitution could greatly influence allele discrimination and gene silencing, thereby contributing to enhancement of ASP-RNAi.
LinkOut: [PMID: 18493311]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | SW480 |
Disease | MIMAT0000226; |
Tools used in this research | Literature survey |
Original Description (Extracted from the article) |
...
"significant differences in target restriction were observed. While low miR-196a concentrations (20 nmol/L) sufficiently restricted HoxB8 mRNA
... - Schimanski CC; Frerichs K; Rahman F; Berger et al., 2009, World journal of gastroenterology. |
Article |
- Schimanski CC; Frerichs K; Rahman F; Berger et al. - World journal of gastroenterology, 2009
AIM: To analyze the relevance of the microRNA miR-196a for colorectal oncogenesis. METHODS: The impact of miR-196a on the restriction targets HoxA7, HoxB8, HoxC8 and HoxD8 was analyzed by reverse transcription polymerase chain reaction (RT-PCR) after transient transfection of SW480 cancer cells. The miR-196a transcription profile in colorectal cancer samples, mucosa samples and diverse cancer cell lines was quantified by RT-PCR. Transiently miR-196a-transfected colorectal cancer cells were used for diverse functional assays in vitro and for a xenograft lung metastasis model in vivo. RESULTS: HoxA7, HoxB8, HoxC8 and HoxD8 were restricted by miR-196a in a dose-dependent and gene-specific manner. High levels of miR-196a activated the AKT signaling pathway as indicated by increased phosphorylation of AKT. In addition, high levels of miR-196a promoted cancer cell detachment, migration, invasion and chemosensitivity towards platin derivatives but did not impact on proliferation or apoptosis. Furthermore, miR-196a increased the development of lung metastases in mice after tail vein injection. CONCLUSION: miR-196a exerts a pro-oncogenic influence in colorectal cancer.
LinkOut: [PMID: 19418581]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Flp-In T-REx 293-hAGO1 cells |
Location of target site | 3'UTR |
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK 293T cells , Neuro2A cells |
Disease | MIMAT0000226 |
Location of target site | 3'UTR |
Tools used in this research | previous_study |
Original Description (Extracted from the article) |
...
"we first compared the miR-196a-mediated expression of the HOXB8 3 0 UTR reporter (FF-Luc:HOXB8) in both wild type and FMRP-knockdown cells. As shown in Fig. 1B
... - Li Y; Tang W; Zhang LR; Zhang CY, 2014, Molecular bioSystems. |
Article |
- Li Y; Tang W; Zhang LR; Zhang CY - Molecular bioSystems, 2014
Fragile X syndrome (FXS) is caused by the loss of expression of fragile X mental retardation protein (FMRP), a selective RNA-binding protein that negatively regulates mRNA substrates. FMRP can regulate the translation via the cross-talk with the miRNA machinery, but the functional association among FMRP, miRNAs and mutual target mRNAs has rarely been studied. In this research, we find that HOXB8 mRNA is a target of FMRP associated with miR-196a-induced silencing, and discover that phosphorylation of FMRP promotes the miR-196a-mediated repression of HOXB8 without affecting the interaction between FMRP and mRNA. We further identify that the FMRP-binding site involved in the miR-196a-mediated repression of HOXB8 locates in the downstream neighbourhood of the miR-196a recognition element in the 3'UTR of HOXB8. Importantly, we reveal that FMRP faces toward the MID domain of AGO2 and interacts with a specific binding pocket (coordination with T544, K533 and K570) in the domain. Our research might provide new insights into both the cross-talk between FMRP and miRNA-mediated regulation of mRNA translation and the molecular pathogenesis of FXS.
LinkOut: [PMID: 24727796]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT000218 | BMP4 | bone morphogenetic protein 4 | 1 | 1 | ||||||||
MIRT000219 | SPRR2C | small proline rich protein 2C (pseudogene) | 3 | 2 | ||||||||
MIRT000220 | S100A9 | S100 calcium binding protein A9 | 3 | 2 | ||||||||
MIRT000221 | KRT5 | keratin 5 | 3 | 2 | ||||||||
MIRT000709 | ANXA1 | annexin A1 | 4 | 2 | ||||||||
MIRT002266 | HOXB8 | homeobox B8 | 5 | 7 | ||||||||
MIRT002940 | HOXA7 | homeobox A7 | 4 | 5 | ||||||||
MIRT002941 | HOXD8 | homeobox D8 | 3 | 3 | ||||||||
MIRT002942 | HOXC8 | homeobox C8 | 6 | 15 | ||||||||
MIRT004244 | HOXB7 | homeobox B7 | 4 | 1 | ||||||||
MIRT004718 | BACH1 | BTB domain and CNC homolog 1 | 6 | 3 | ||||||||
MIRT004719 | HMOX1 | heme oxygenase 1 | 4 | 1 | ||||||||
MIRT005065 | CDKN1B | cyclin dependent kinase inhibitor 1B | 6 | 7 | ||||||||
MIRT006802 | HMGA1 | high mobility group AT-hook 1 | 5 | 5 | ||||||||
MIRT006803 | HMGA2 | high mobility group AT-hook 2 | 5 | 7 | ||||||||
MIRT006906 | HOXA5 | homeobox A5 | 5 | 3 | ||||||||
MIRT026026 | IKBKB | inhibitor of nuclear factor kappa B kinase subunit beta | 1 | 1 | ||||||||
MIRT026027 | PDCD4 | programmed cell death 4 | 1 | 1 | ||||||||
MIRT026028 | SRRT | serrate, RNA effector molecule | 2 | 9 | ||||||||
MIRT026029 | DIEXF | digestive organ expansion factor homolog (zebrafish) | 1 | 1 | ||||||||
MIRT026030 | ZBTB24 | zinc finger and BTB domain containing 24 | 1 | 1 | ||||||||
MIRT026031 | NR4A1 | nuclear receptor subfamily 4 group A member 1 | 1 | 1 | ||||||||
MIRT026032 | ABT1 | activator of basal transcription 1 | 1 | 1 | ||||||||
MIRT026033 | SPATA2 | spermatogenesis associated 2 | 1 | 1 | ||||||||
MIRT026034 | NHLRC3 | NHL repeat containing 3 | 1 | 1 | ||||||||
MIRT026035 | RPUSD2 | RNA pseudouridylate synthase domain containing 2 | 1 | 1 | ||||||||
MIRT026036 | CEP120 | centrosomal protein 120 | 1 | 1 | ||||||||
MIRT026037 | PHC3 | polyhomeotic homolog 3 | 1 | 1 | ||||||||
MIRT026038 | ZBTB6 | zinc finger and BTB domain containing 6 | 1 | 1 | ||||||||
MIRT026039 | C9orf41 | carnosine N-methyltransferase 1 | 1 | 1 | ||||||||
MIRT026040 | PNP | purine nucleoside phosphorylase | 1 | 1 | ||||||||
MIRT026041 | COPS3 | COP9 signalosome subunit 3 | 1 | 1 | ||||||||
MIRT026042 | NUP50 | nucleoporin 50 | 1 | 1 | ||||||||
MIRT026043 | ZNF763 | zinc finger protein 763 | 1 | 1 | ||||||||
MIRT026044 | FOXJ3 | forkhead box J3 | 1 | 1 | ||||||||
MIRT026045 | BIN3 | bridging integrator 3 | 1 | 1 | ||||||||
MIRT026046 | C12orf4 | chromosome 12 open reading frame 4 | 1 | 1 | ||||||||
MIRT026047 | RAD9A | RAD9 checkpoint clamp component A | 1 | 1 | ||||||||
MIRT026048 | PCGF3 | polycomb group ring finger 3 | 1 | 1 | ||||||||
MIRT026049 | KATNAL1 | katanin catalytic subunit A1 like 1 | 1 | 1 | ||||||||
MIRT026050 | SLC10A7 | solute carrier family 10 member 7 | 1 | 1 | ||||||||
MIRT026051 | LBR | lamin B receptor | 1 | 1 | ||||||||
MIRT026052 | BCL11A | B-cell CLL/lymphoma 11A | 1 | 1 | ||||||||
MIRT026053 | GLMN | glomulin, FKBP associated protein | 1 | 1 | ||||||||
MIRT026054 | STK40 | serine/threonine kinase 40 | 1 | 1 | ||||||||
MIRT026055 | TMEM135 | transmembrane protein 135 | 1 | 1 | ||||||||
MIRT026056 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 2 | 3 | ||||||||
MIRT026057 | POLR2D | RNA polymerase II subunit D | 2 | 5 | ||||||||
MIRT026058 | LGR4 | leucine rich repeat containing G protein-coupled receptor 4 | 1 | 1 | ||||||||
MIRT026059 | IGF2BP3 | insulin like growth factor 2 mRNA binding protein 3 | 2 | 4 | ||||||||
MIRT026060 | ESPL1 | extra spindle pole bodies like 1, separase | 1 | 1 | ||||||||
MIRT026061 | RFX5 | regulatory factor X5 | 1 | 1 | ||||||||
MIRT026062 | SYT9 | synaptotagmin 9 | 1 | 1 | ||||||||
MIRT026063 | PEX13 | peroxisomal biogenesis factor 13 | 1 | 1 | ||||||||
MIRT026064 | IGF1R | insulin like growth factor 1 receptor | 1 | 1 | ||||||||
MIRT026065 | SMCR7L | mitochondrial elongation factor 1 | 1 | 4 | ||||||||
MIRT026066 | SLC30A6 | solute carrier family 30 member 6 | 2 | 3 | ||||||||
MIRT026067 | RAB31 | RAB31, member RAS oncogene family | 1 | 1 | ||||||||
MIRT026068 | KPNA5 | karyopherin subunit alpha 5 | 1 | 1 | ||||||||
MIRT026069 | SLC20A1 | solute carrier family 20 member 1 | 1 | 1 | ||||||||
MIRT026070 | TIMM23 | translocase of inner mitochondrial membrane 23 | 1 | 1 | ||||||||
MIRT026071 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT026072 | SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 1 | 1 | ||||||||
MIRT026073 | CCNT2 | cyclin T2 | 1 | 1 | ||||||||
MIRT026074 | CCND2 | cyclin D2 | 1 | 1 | ||||||||
MIRT026075 | USP24 | ubiquitin specific peptidase 24 | 1 | 1 | ||||||||
MIRT026076 | TRPC3 | transient receptor potential cation channel subfamily C member 3 | 2 | 4 | ||||||||
MIRT026077 | SMC3 | structural maintenance of chromosomes 3 | 1 | 1 | ||||||||
MIRT026078 | TMEM2 | transmembrane protein 2 | 1 | 1 | ||||||||
MIRT026079 | RDH10 | retinol dehydrogenase 10 | 1 | 1 | ||||||||
MIRT026080 | C11orf57 | chromosome 11 open reading frame 57 | 2 | 5 | ||||||||
MIRT026081 | FAM127A | retrotransposon Gag like 8C | 2 | 4 | ||||||||
MIRT026082 | PRUNE2 | prune homolog 2 | 2 | 3 | ||||||||
MIRT026083 | SPRYD4 | SPRY domain containing 4 | 1 | 1 | ||||||||
MIRT026084 | TMEM161B | transmembrane protein 161B | 1 | 1 | ||||||||
MIRT026085 | CPEB3 | cytoplasmic polyadenylation element binding protein 3 | 1 | 1 | ||||||||
MIRT026086 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT026087 | RAB7L1 | RAB29, member RAS oncogene family | 1 | 1 | ||||||||
MIRT026088 | ITGAV | integrin subunit alpha V | 1 | 1 | ||||||||
MIRT026089 | CPD | carboxypeptidase D | 1 | 1 | ||||||||
MIRT026090 | ZNF354B | zinc finger protein 354B | 1 | 1 | ||||||||
MIRT026091 | TMEM194A | nuclear envelope integral membrane protein 1 | 1 | 1 | ||||||||
MIRT026092 | EPHA7 | EPH receptor A7 | 1 | 1 | ||||||||
MIRT026093 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | 1 | 1 | ||||||||
MIRT026094 | DFFA | DNA fragmentation factor subunit alpha | 2 | 2 | ||||||||
MIRT026095 | TSPAN12 | tetraspanin 12 | 1 | 1 | ||||||||
MIRT026096 | LIN28B | lin-28 homolog B | 1 | 1 | ||||||||
MIRT026097 | ARHGAP28 | Rho GTPase activating protein 28 | 1 | 1 | ||||||||
MIRT026098 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 1 | 1 | ||||||||
MIRT026099 | CCDC47 | coiled-coil domain containing 47 | 1 | 1 | ||||||||
MIRT026100 | HAND1 | heart and neural crest derivatives expressed 1 | 4 | 2 | ||||||||
MIRT026101 | LLGL1 | LLGL1, scribble cell polarity complex component | 1 | 1 | ||||||||
MIRT048150 | PGAM1 | phosphoglycerate mutase 1 | 1 | 1 | ||||||||
MIRT048151 | PSMC3 | proteasome 26S subunit, ATPase 3 | 1 | 1 | ||||||||
MIRT048152 | TMX2 | thioredoxin related transmembrane protein 2 | 1 | 1 | ||||||||
MIRT048153 | KLHL7 | kelch like family member 7 | 1 | 1 | ||||||||
MIRT048154 | RFC2 | replication factor C subunit 2 | 1 | 1 | ||||||||
MIRT048155 | GLUL | glutamate-ammonia ligase | 1 | 1 | ||||||||
MIRT048156 | NRXN1 | neurexin 1 | 1 | 1 | ||||||||
MIRT048157 | GSTK1 | glutathione S-transferase kappa 1 | 1 | 1 | ||||||||
MIRT048158 | HIST2H4B | histone cluster 2 H4 family member b | 1 | 1 | ||||||||
MIRT048159 | SPEN | spen family transcriptional repressor | 1 | 1 | ||||||||
MIRT048160 | TAF15 | TATA-box binding protein associated factor 15 | 1 | 1 | ||||||||
MIRT048161 | SAP18 | Sin3A associated protein 18 | 1 | 1 | ||||||||
MIRT048162 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 1 | 1 | ||||||||
MIRT048163 | MSL3 | MSL complex subunit 3 | 1 | 1 | ||||||||
MIRT048164 | TSKU | tsukushi, small leucine rich proteoglycan | 1 | 1 | ||||||||
MIRT048165 | KMT2C | lysine methyltransferase 2C | 1 | 1 | ||||||||
MIRT048166 | LYRM2 | LYR motif containing 2 | 1 | 1 | ||||||||
MIRT048167 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 1 | 1 | ||||||||
MIRT048168 | C19orf55 | proline and serine rich 3 | 1 | 1 | ||||||||
MIRT048169 | LRP2 | LDL receptor related protein 2 | 1 | 1 | ||||||||
MIRT048170 | ND4L | NADH dehydrogenase, subunit 4L (complex I) | 1 | 1 | ||||||||
MIRT048171 | NKX6-1 | NK6 homeobox 1 | 1 | 1 | ||||||||
MIRT048172 | BRMS1L | breast cancer metastasis-suppressor 1 like | 1 | 1 | ||||||||
MIRT048173 | RPS2 | ribosomal protein S2 | 1 | 1 | ||||||||
MIRT048174 | RBMX | RNA binding motif protein, X-linked | 1 | 1 | ||||||||
MIRT048175 | ZFP64 | ZFP64 zinc finger protein | 1 | 1 | ||||||||
MIRT048176 | REEP2 | receptor accessory protein 2 | 1 | 1 | ||||||||
MIRT048177 | MED13 | mediator complex subunit 13 | 1 | 1 | ||||||||
MIRT048178 | MYCBP2 | MYC binding protein 2, E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT048179 | TRAPPC9 | trafficking protein particle complex 9 | 1 | 1 | ||||||||
MIRT048180 | DNTTIP2 | deoxynucleotidyltransferase terminal interacting protein 2 | 1 | 1 | ||||||||
MIRT048181 | VDAC3 | voltage dependent anion channel 3 | 1 | 1 | ||||||||
MIRT048182 | ZNF529 | zinc finger protein 529 | 1 | 1 | ||||||||
MIRT048183 | EWSR1 | EWS RNA binding protein 1 | 1 | 1 | ||||||||
MIRT048184 | ATP6V1B2 | ATPase H+ transporting V1 subunit B2 | 1 | 1 | ||||||||
MIRT048185 | RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 1 | 1 | ||||||||
MIRT048186 | APP | amyloid beta precursor protein | 1 | 1 | ||||||||
MIRT048187 | PROSER1 | proline and serine rich 1 | 1 | 1 | ||||||||
MIRT048188 | HIST1H2BB | histone cluster 1 H2B family member b | 1 | 1 | ||||||||
MIRT048189 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | 1 | 1 | ||||||||
MIRT048190 | TUBA1B | tubulin alpha 1b | 1 | 1 | ||||||||
MIRT048191 | USP19 | ubiquitin specific peptidase 19 | 1 | 1 | ||||||||
MIRT048192 | COX3 | cytochrome c oxidase III | 1 | 1 | ||||||||
MIRT048193 | PSMD8 | proteasome 26S subunit, non-ATPase 8 | 1 | 1 | ||||||||
MIRT048194 | TRA2B | transformer 2 beta homolog | 1 | 1 | ||||||||
MIRT048195 | MRPL35 | mitochondrial ribosomal protein L35 | 1 | 1 | ||||||||
MIRT048196 | KCTD1 | potassium channel tetramerization domain containing 1 | 1 | 1 | ||||||||
MIRT048197 | UBE2C | ubiquitin conjugating enzyme E2 C | 1 | 1 | ||||||||
MIRT048198 | ZNF581 | zinc finger protein 581 | 1 | 1 | ||||||||
MIRT048199 | CNOT11 | CCR4-NOT transcription complex subunit 11 | 1 | 1 | ||||||||
MIRT048200 | POTEG | POTE ankyrin domain family member G | 1 | 1 | ||||||||
MIRT048201 | MTRF1L | mitochondrial translational release factor 1 like | 1 | 1 | ||||||||
MIRT048202 | SRP9 | signal recognition particle 9 | 2 | 5 | ||||||||
MIRT048203 | BCORL1 | BCL6 corepressor like 1 | 1 | 1 | ||||||||
MIRT048204 | NRBP1 | nuclear receptor binding protein 1 | 1 | 1 | ||||||||
MIRT048205 | LRRC41 | leucine rich repeat containing 41 | 1 | 1 | ||||||||
MIRT048206 | ATP6 | ATP synthase F0 subunit 6 | 1 | 1 | ||||||||
MIRT048207 | FKTN | fukutin | 1 | 1 | ||||||||
MIRT048208 | RANBP9 | RAN binding protein 9 | 1 | 1 | ||||||||
MIRT048209 | SYVN1 | synoviolin 1 | 1 | 1 | ||||||||
MIRT048210 | NR2F6 | nuclear receptor subfamily 2 group F member 6 | 1 | 1 | ||||||||
MIRT048211 | ATG16L1 | autophagy related 16 like 1 | 1 | 1 | ||||||||
MIRT048212 | EIF2S3 | eukaryotic translation initiation factor 2 subunit gamma | 1 | 1 | ||||||||
MIRT048213 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | 1 | 1 | ||||||||
MIRT048214 | HAUS6 | HAUS augmin like complex subunit 6 | 1 | 1 | ||||||||
MIRT048215 | CKAP2L | cytoskeleton associated protein 2 like | 1 | 1 | ||||||||
MIRT048216 | IFNGR1 | interferon gamma receptor 1 | 1 | 1 | ||||||||
MIRT048217 | ANXA7 | annexin A7 | 1 | 1 | ||||||||
MIRT048218 | ENAH | ENAH, actin regulator | 1 | 1 | ||||||||
MIRT048219 | FOXO1 | forkhead box O1 | 9 | 3 | ||||||||
MIRT048220 | NDFIP1 | Nedd4 family interacting protein 1 | 1 | 1 | ||||||||
MIRT048221 | LSM14A | LSM14A, mRNA processing body assembly factor | 1 | 1 | ||||||||
MIRT048222 | ATP1A1 | ATPase Na+/K+ transporting subunit alpha 1 | 1 | 1 | ||||||||
MIRT048223 | SLC25A17 | solute carrier family 25 member 17 | 1 | 1 | ||||||||
MIRT048224 | ZNF398 | zinc finger protein 398 | 1 | 1 | ||||||||
MIRT048225 | RASSF7 | Ras association domain family member 7 | 1 | 1 | ||||||||
MIRT048226 | SBF1 | SET binding factor 1 | 1 | 1 | ||||||||
MIRT048227 | TP53RK | TP53 regulating kinase | 1 | 1 | ||||||||
MIRT048228 | MED12 | mediator complex subunit 12 | 1 | 1 | ||||||||
MIRT048229 | FLNA | filamin A | 1 | 1 | ||||||||
MIRT048230 | CCNE2 | cyclin E2 | 1 | 1 | ||||||||
MIRT048231 | CANX | calnexin | 1 | 1 | ||||||||
MIRT048232 | PRPF8 | pre-mRNA processing factor 8 | 1 | 1 | ||||||||
MIRT048233 | FRS2 | fibroblast growth factor receptor substrate 2 | 1 | 1 | ||||||||
MIRT048234 | KIF18B | kinesin family member 18B | 1 | 1 | ||||||||
MIRT048235 | U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 1 | 1 | ||||||||
MIRT048236 | SH3GL3 | SH3 domain containing GRB2 like 3, endophilin A3 | 1 | 1 | ||||||||
MIRT048237 | VCP | valosin containing protein | 1 | 1 | ||||||||
MIRT048238 | ETV3 | ETS variant 3 | 1 | 1 | ||||||||
MIRT048239 | BCS1L | BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone | 1 | 1 | ||||||||
MIRT048240 | ND5 | NADH dehydrogenase, subunit 5 (complex I) | 1 | 1 | ||||||||
MIRT048241 | ZCCHC11 | zinc finger CCHC-type containing 11 | 1 | 1 | ||||||||
MIRT048242 | RALGPS2 | Ral GEF with PH domain and SH3 binding motif 2 | 1 | 1 | ||||||||
MIRT048243 | HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT048244 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT048245 | UQCRC2 | ubiquinol-cytochrome c reductase core protein II | 1 | 1 | ||||||||
MIRT048246 | EIF2B4 | eukaryotic translation initiation factor 2B subunit delta | 1 | 1 | ||||||||
MIRT048247 | GMFB | glia maturation factor beta | 1 | 1 | ||||||||
MIRT048248 | PALLD | palladin, cytoskeletal associated protein | 1 | 1 | ||||||||
MIRT048249 | CASP3 | caspase 3 | 1 | 1 | ||||||||
MIRT048250 | VCL | vinculin | 1 | 1 | ||||||||
MIRT048251 | IPO5 | importin 5 | 1 | 1 | ||||||||
MIRT048252 | PATL1 | PAT1 homolog 1, processing body mRNA decay factor | 1 | 1 | ||||||||
MIRT048253 | NAP1L4 | nucleosome assembly protein 1 like 4 | 1 | 1 | ||||||||
MIRT048254 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 1 | ||||||||
MIRT048255 | TUBB | tubulin beta class I | 1 | 1 | ||||||||
MIRT048256 | CCND1 | cyclin D1 | 1 | 1 | ||||||||
MIRT048257 | GID8 | GID complex subunit 8 homolog | 1 | 1 | ||||||||
MIRT048258 | VDAC2 | voltage dependent anion channel 2 | 1 | 1 | ||||||||
MIRT048259 | SLC6A8 | solute carrier family 6 member 8 | 1 | 1 | ||||||||
MIRT048260 | FXR2 | FMR1 autosomal homolog 2 | 1 | 1 | ||||||||
MIRT048261 | SCN11A | sodium voltage-gated channel alpha subunit 11 | 1 | 1 | ||||||||
MIRT048262 | AHSA1 | activator of HSP90 ATPase activity 1 | 1 | 1 | ||||||||
MIRT048263 | ATG9A | autophagy related 9A | 1 | 1 | ||||||||
MIRT048264 | NOTCH2 | notch 2 | 1 | 1 | ||||||||
MIRT048265 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 1 | 1 | ||||||||
MIRT048266 | ND4 | NADH dehydrogenase, subunit 4 (complex I) | 2 | 1 | ||||||||
MIRT048267 | OAT | ornithine aminotransferase | 1 | 1 | ||||||||
MIRT048268 | TRAP1 | TNF receptor associated protein 1 | 1 | 1 | ||||||||
MIRT048269 | SKI | SKI proto-oncogene | 1 | 1 | ||||||||
MIRT048270 | GLTP | glycolipid transfer protein | 1 | 1 | ||||||||
MIRT048271 | EEF2 | eukaryotic translation elongation factor 2 | 1 | 1 | ||||||||
MIRT048272 | LSM3 | LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated | 1 | 1 | ||||||||
MIRT048273 | GRIK4 | glutamate ionotropic receptor kainate type subunit 4 | 1 | 1 | ||||||||
MIRT048274 | PDE6D | phosphodiesterase 6D | 1 | 1 | ||||||||
MIRT048275 | MPP2 | membrane palmitoylated protein 2 | 1 | 1 | ||||||||
MIRT048276 | SAR1B | secretion associated Ras related GTPase 1B | 2 | 3 | ||||||||
MIRT048277 | MAP4 | microtubule associated protein 4 | 1 | 1 | ||||||||
MIRT048278 | RAB21 | RAB21, member RAS oncogene family | 1 | 1 | ||||||||
MIRT048279 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 1 | 1 | ||||||||
MIRT048280 | OGFRL1 | opioid growth factor receptor like 1 | 1 | 1 | ||||||||
MIRT048281 | GOT2 | glutamic-oxaloacetic transaminase 2 | 1 | 1 | ||||||||
MIRT048282 | NRDE2 | NRDE-2, necessary for RNA interference, domain containing | 1 | 1 | ||||||||
MIRT048283 | SBNO1 | strawberry notch homolog 1 | 1 | 1 | ||||||||
MIRT053067 | NTN4 | netrin 4 | 2 | 1 | ||||||||
MIRT054025 | RDX | radixin | 5 | 5 | ||||||||
MIRT056750 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT057645 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 4 | ||||||||
MIRT076226 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 6 | ||||||||
MIRT083303 | ZCCHC3 | zinc finger CCHC-type containing 3 | 2 | 2 | ||||||||
MIRT095769 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 10 | ||||||||
MIRT187720 | SUOX | sulfite oxidase | 2 | 2 | ||||||||
MIRT191923 | CALM1 | calmodulin 1 | 2 | 2 | ||||||||
MIRT205504 | SP100 | SP100 nuclear antigen | 2 | 2 | ||||||||
MIRT209857 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT229841 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT230833 | TBRG1 | transforming growth factor beta regulator 1 | 2 | 2 | ||||||||
MIRT235376 | CALM3 | calmodulin 3 | 2 | 2 | ||||||||
MIRT251626 | KCNJ2 | potassium voltage-gated channel subfamily J member 2 | 2 | 2 | ||||||||
MIRT252333 | SALL3 | spalt like transcription factor 3 | 2 | 2 | ||||||||
MIRT255317 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT324734 | ACER2 | alkaline ceramidase 2 | 4 | 3 | ||||||||
MIRT386075 | ZNF609 | zinc finger protein 609 | 2 | 2 | ||||||||
MIRT402060 | ATP6V1F | ATPase H+ transporting V1 subunit F | 2 | 4 | ||||||||
MIRT437422 | NFKBIA | NFKB inhibitor alpha | 4 | 2 | ||||||||
MIRT437980 | TYMS | thymidylate synthetase | 1 | 1 | ||||||||
MIRT437981 | NRP2 | neuropilin 2 | 1 | 1 | ||||||||
MIRT437982 | LSP1 | lymphocyte-specific protein 1 | 1 | 1 | ||||||||
MIRT439104 | MYC | MYC proto-oncogene, bHLH transcription factor | 0 | 1 | ||||||||
MIRT447143 | KIF27 | kinesin family member 27 | 2 | 2 | ||||||||
MIRT447559 | C14orf37 | chromosome 14 open reading frame 37 | 2 | 2 | ||||||||
MIRT449961 | FMNL3 | formin like 3 | 2 | 2 | ||||||||
MIRT465087 | TSPAN3 | tetraspanin 3 | 2 | 2 | ||||||||
MIRT470426 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 2 | ||||||||
MIRT472726 | MTUS1 | microtubule associated scaffold protein 1 | 2 | 6 | ||||||||
MIRT473801 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT474507 | KLHDC8B | kelch domain containing 8B | 2 | 2 | ||||||||
MIRT474917 | KCTD21 | potassium channel tetramerization domain containing 21 | 2 | 2 | ||||||||
MIRT486549 | DCTN4 | dynactin subunit 4 | 2 | 2 | ||||||||
MIRT492430 | RGL2 | ral guanine nucleotide dissociation stimulator like 2 | 2 | 2 | ||||||||
MIRT493925 | FAM127B | retrotransposon Gag like 8A | 2 | 4 | ||||||||
MIRT500972 | SPTSSA | serine palmitoyltransferase small subunit A | 2 | 2 | ||||||||
MIRT501431 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT502410 | GATA6 | GATA binding protein 6 | 2 | 8 | ||||||||
MIRT506368 | NUP155 | nucleoporin 155 | 2 | 6 | ||||||||
MIRT507497 | E2F7 | E2F transcription factor 7 | 2 | 6 | ||||||||
MIRT520041 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT522366 | NAP1L1 | nucleosome assembly protein 1 like 1 | 2 | 4 | ||||||||
MIRT531281 | SLC7A7 | solute carrier family 7 member 7 | 2 | 2 | ||||||||
MIRT543674 | FAM135A | family with sequence similarity 135 member A | 2 | 2 | ||||||||
MIRT545199 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 2 | ||||||||
MIRT546336 | TGFBR3 | transforming growth factor beta receptor 3 | 2 | 2 | ||||||||
MIRT546452 | SLC9A7 | solute carrier family 9 member A7 | 2 | 2 | ||||||||
MIRT546787 | RCC2 | regulator of chromosome condensation 2 | 2 | 4 | ||||||||
MIRT547253 | NXPE3 | neurexophilin and PC-esterase domain family member 3 | 2 | 2 | ||||||||
MIRT547454 | MBD4 | methyl-CpG binding domain 4, DNA glycosylase | 2 | 2 | ||||||||
MIRT547581 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT547902 | HOXA9 | homeobox A9 | 2 | 4 | ||||||||
MIRT549503 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT549583 | ZNF850 | zinc finger protein 850 | 2 | 2 | ||||||||
MIRT551888 | MMS22L | MMS22 like, DNA repair protein | 2 | 2 | ||||||||
MIRT552125 | MED10 | mediator complex subunit 10 | 2 | 2 | ||||||||
MIRT554188 | SLC35E2B | solute carrier family 35 member E2B | 2 | 2 | ||||||||
MIRT555552 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT556285 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT556980 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | 2 | 2 | ||||||||
MIRT559183 | BRAP | BRCA1 associated protein | 2 | 2 | ||||||||
MIRT561215 | ZSWIM1 | zinc finger SWIM-type containing 1 | 2 | 2 | ||||||||
MIRT562352 | EXOC8 | exocyst complex component 8 | 2 | 2 | ||||||||
MIRT565603 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT575599 | Gnl1 | guanine nucleotide binding protein-like 1 | 2 | 3 | ||||||||
MIRT610363 | GNL1 | G protein nucleolar 1 (putative) | 2 | 3 | ||||||||
MIRT617860 | FMO4 | flavin containing monooxygenase 4 | 2 | 2 | ||||||||
MIRT698193 | TMEM66 | store-operated calcium entry associated regulatory factor | 1 | 1 | ||||||||
MIRT704411 | CTPS1 | CTP synthase 1 | 2 | 2 | ||||||||
MIRT732864 | NARS | asparaginyl-tRNA synthetase | 3 | 0 | ||||||||
MIRT732867 | AJAP1 | adherens junctions associated protein 1 | 3 | 0 | ||||||||
MIRT732868 | COL24A1 | collagen type XXIV alpha 1 chain | 3 | 0 | ||||||||
MIRT735738 | RASSF4 | Ras association domain family member 4 | 3 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|